about
Replicon RNA Viral Vectors as VaccinesDendrimer-RNA nanoparticles generate protective immunity against lethal Ebola, H1N1 influenza, and Toxoplasma gondii challenges with a single doseFuture prospects for gene delivery systems.Viral and Synthetic RNA Vector Technologies and Applications.Pseudo-typed Semliki Forest virus delivers EGFP into neurons.Vaccine Delivery Methods into the FutureAlphavirus-Based Vaccines.
P2860
Q28076639-BC5C5D92-B7C3-452E-8F58-3E95904B2307Q37126611-E25C03A6-0F77-40D0-80E0-F38786765E9CQ38760958-68429055-0508-4C42-B8C5-D7DC9CAF2D01Q38885624-C909C492-32AE-4297-8588-97B87A1A1486Q40542588-B86733FF-37A0-4B32-8DF4-1DDDCD4F4E05Q42434139-5BDA2D27-1717-4879-8824-491767141885Q51072912-7630204F-C7F6-43EB-A128-910D2862AF72
P2860
description
article
@en
im Mai 2015 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в травні 2015
@uk
name
Alphaviruses in gene therapy
@en
Alphaviruses in gene therapy
@nl
type
label
Alphaviruses in gene therapy
@en
Alphaviruses in gene therapy
@nl
prefLabel
Alphaviruses in gene therapy
@en
Alphaviruses in gene therapy
@nl
P2860
P921
P356
P1433
P1476
Alphaviruses in gene therapy
@en
P2093
Kenneth Lundstrom
P2860
P304
P356
10.3390/V7052321
P407
P577
2015-05-07T00:00:00Z